GLOBAL MYOMECTOMY MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Market News

Global Myomectomy Market- Recent Developments

Business Development Activities by the Market Players

• In October 2021, Gynesonics, a women's healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced that Dr. John Thoppil is the first physician in the state of Texas to offer its Sonata treatment to women with symptomatic uterine fibroids as an office-based procedure at his River Place OB/GYN facility in Austin, U.S.
• In September 2021, Gynesonics, a women's healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced the Food and Drug Administration (FDA) has given clearance of the Sonata® System 2.2 which provides important new benefits for facilities, physicians, and patients.
• In August 23, 2021, Hologic, Inc., a global leader in women's health, announced that Anthem Blue Cross Blue Shield, the second largest health plan in the U.S., has updated its medical policy to cover aadiofrequency ablation (LAP-RFA), which includes the Acessa procedure (CPT Code 58674), for women suffering from uterine fibroids.